Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-25-009049
Filing Date
2025-08-25
Accepted
2025-08-25 12:36:03
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27555
2 filename2.txt TEXT-EXTRACT 920
  Complete submission text file 0000000000-25-009049.txt   39616
Mailing Address 1600 WEST END AVENUE SUITE 1300 NASHVILLE TN 37203
Business Address 1600 WEST END AVENUE SUITE 1300 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filed for) CIK: 0001087294 (see all company filings)

EIN.: 621765329 | State of Incorp.: TN | Fiscal Year End: 1231
Type: UPLOAD | File No.: 001-33637
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)